Company patents

DATADOSE, LLC

DATADOSE, LLC's patent strategy reveals a surprising and almost exclusive focus on medical devices, with 100.0% of its portfolio in Healthcare Informatics and 98.3% in Drug Delivery Devices, both showing explosive growth of over 318% so far in 2026 after a complete absence of filings in 2024. The emergence of Education & Training patents, accounting for 15.3% of its portfolio with 9 filings so far in 2026, suggests a nascent but unexpected diversification beyond its core medical device innovations.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

59 US filings (since 2023) · 3 categories · 4 themes

Patents

Showing 11-20 of 61

Page 2 of 7
US 20260124392 A1APPLICATION
A61M5/172

INTELLIGENT DOSING PLATFORM WITH ATHLETIC COMPETITION COMPLIANCE AND ANTI-DOPING INTEGRATION FOR INJECTABLE MEDICATION ADMINISTRATION

Filed:2025-10-29Pub:2026-05-07
Applicant:DATADOSE, LLC

An intelligent dosing platform incorporating comprehensive athletic competition compliance and anti-doping integration capabilities for injectable medication administration across Olympic competitions, professional athletics, and collegiate sports. The platform includes competition compliance modules configured to monitor medication administration while ensuring adherence to competition rules and anti-doping regulations, drug testing integration modules that coordinate with World Anti-Doping Agency (WADA) systems and national anti-doping organizations, and athlete monitoring modules that track therapeutic use exemption compliance. The system features real-time monitoring capabilities during training periods and competition events, alert systems for potential violations and compliance deviations, and documentation modules maintaining tamper-proof records for regulatory bodies. Therapeutic use exemption management modules validate medically necessary treatments against sport-specific regulations, while secure communication modules facilitate coordination between athletes, medical staff, competition officials, and anti-doping authorities. The platform incorporates substance verification, compliance scoring, and data analytics capabilities for comprehensive athletic medication compliance management.